|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash, current | ||||||||||||||||||||
| Investments in equity securities | ||||||||||||||||||||
| Accounts receivable, less allowance for expected credit losses of $289 and $275, respectively | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Note receivable, current portion | ||||||||||||||||||||
| Prepaid and other | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $7,632 and $6,367, respectively | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization of $5,117 and $4,795, respectively | ||||||||||||||||||||
| Long-term investments | ||||||||||||||||||||
| Notes receivable, net of current portion | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Restricted cash, non-current | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued salaries, commissions, and benefits | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Operating lease obligations, current | ||||||||||||||||||||
| Operating and finance lease obligations, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Operating lease obligations | ||||||||||||||||||||
| Long-term debt, net of current portion | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Series A preferred stock, $0.001 par value; 10,000 shares authorized: 2,776 and 2,691 shares issued; 2,455 and 2,370 shares outstanding, respectively | ||||||||||||||||||||
| Common stock, $0.001 par value, 20,000 shares authorized; 5,398 and 5,366 shares issued; 3,699 and 3,755 shares outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of applicable tax | ||||||||||||||||||||
| Treasury stock, at cost: 1,699 and 1,611 common shares, respectively, and 321 preferred shares for both periods | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
